Veozah Vms denied as not medically necessary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for veozah vms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC May Deny Veozah for VMS as Not Medically Necessary

Veozah (fezolinetant) is an FDA-approved non-hormonal treatment for moderate-to-severe vasomotor symptoms (VMS) — hot flashes and night sweats — associated with menopause. UnitedHealthcare's medical-necessity denial typically means the submitted clinical information did not satisfy one or more criteria in UHC's coverage policy: the severity of VMS was not adequately documented, prior treatments were not sufficiently documented, or the prescriber's rationale for this specific agent was absent or insufficiently detailed.

## Why This Is Appealable

Medical-necessity denials are among the most commonly reversed on appeal when the clinical record is properly marshaled. UHC must base its determination on the clinical evidence in your file, and the denial frequently results from a documentation gap rather than a true clinical disagreement. A well-organized appeal that maps each UHC coverage criterion to a specific chart finding — rather than a general appeal letter — has a significantly higher reversal rate.

## Federal Appeal Framework

• Internal appeal (ACA/ERISA §503): You have the right to a full-and-fair review. Request the specific clinical criteria UHC applied and the clinical rationale for denial. Submit new or supplemental clinical evidence addressing each gap. Standard decision: 30 days; expedited: 72 hours.
• Expedited appeal: Available if severe VMS is significantly impairing daily function, sleep, or work capacity, or if the condition has safety implications (e.g., interaction with other conditions).
• External review (ACA §2719): After a final internal denial, request independent external review within approximately four months. The independent reviewer applies recognized clinical standards, not UHC's internal criteria alone.

## Documentation to Gather

1. Severity documentation: Office notes quantifying VMS frequency (episodes per day or week) and their functional impact on sleep, work, and daily activities — in the prescriber's own words, not just a checked box. 2. Menopause diagnosis confirmation: Clinical or laboratory confirmation of menopause or menopausal transition, with ICD-10 code. 3. Prior treatment history with outcomes: Dates, agents, duration, and documented outcomes of prior VMS treatments (hormone therapy, other non-hormonal agents). Include documented intolerance or contraindications with clinical rationale. 4. Hormone therapy contraindication (if applicable): If HT is not appropriate for this patient, the prescriber must document the specific clinical reason (e.g., hormone-sensitive cancer history, cardiovascular risk, patient preference with clinical support). 5. Prescriber medical-necessity letter: Should state that VMS severity meets the threshold for treatment, that Veozah is medically appropriate given the patient's history, and that the request is consistent with the FDA-approved label and relevant professional society guidance (e.g., NAMS).

## Criteria-Mapping Structure for Your Appeal Letter

Obtain UHC's current coverage policy for Veozah and map each criterion to your chart evidence:

| UHC Coverage Criterion | Supporting Chart Evidence | |---|---| | Diagnosis of menopause-related VMS | ICD-10 code; clinical/lab confirmation; date of diagnosis | | Moderate-to-severe symptom severity | Frequency/severity documentation from office notes | | Prior treatment trial or documented contraindication | Dates, agents, outcomes, or clinical contraindication rationale | | Prescriber attestation of medical necessity | Letter from treating clinician |

Submit this table as part of your appeal cover letter so the reviewer can verify compliance with each criterion without searching through the full record.